UK
Sign In
Search
Trending stocks
16 Apr 2026, 18:49
Beximco Pharmaceuticals
Industry: Pharmaceuticals & Biotechnology
Ticker
Exchange
ISIN
$BXP
LSE AIM
US0885792061
Recent news
Carnival Net Income dropped on 442% and Revenue dropped on 73.1%
Unisys Corp reports 4,465% Net Income growth in 2020 while 31.3% Revenue decline
Northamber Net Income surged on 1,523%
International Bus Mach Corp reports 40.7% Net Income decline in 2020 and 3.2 pp EBITDA Margin decline from 20.7% to 17.5%
Blue Prism Group plc revenue surged on 40% and EBITDA Margin surged on 28.9 pp from -78.3% to -49.4%
Tui Ag EBITDA dropped on 220% and Revenue dropped on 58.0%
Zytronic Net Income dropped on 111% and EBITDA Margin dropped on 15.0 pp from 20.6% to 5.6%
Image Scan Hldgs revenue surged on 47.3% and EBITDA Margin surged on 21.0 pp from -16.0% to 5.0%
Oxford Metrics Net Income dropped on 61.6% and Revenue dropped on 14.3%
I-Nexus Global Plc revenue dropped on 14.3%
Twit about BXP stock
Share your investment idea or question on
Beximco Pharmaceuticals
stock:
$BXP
#Bullish
#Bearish
POST
Latest twits on Beximco Pharmaceuticals (BXP)
No twits yet. Be the first to post!
Have a question about BXP? Ask and other investors will be eager to help you.
Have an idea about BXP? Share it with other investors.
Beximco Pharmaceuticals news
04 Nov 2016 Beximco Pharmaceuticals reports 26.0% CAPEX decline while 6.3% Revenue growth
18 May 2016 Beximco Pharmaceuticals Net Income surged on 27.9% in 2015 and Revenue surged on 15.7%
Beximco Pharmaceuticals stock price chart
Beximco Pharmaceuticals financials
mln. BDT
FY2010
FY2011
FY2012
Revenue
6,491
7,890
9,289
EBITDA
2,071
2,406
2,706
Net income
1,052
1,199
1,319
CAPEX
2,595
1,112
1,034
Debt
3,891
2,006
3,661
Cash
1,471
518.8
553.0
Beximco Pharmaceuticals news
04 Nov 2016 Beximco Pharmaceuticals reports 26.0% CAPEX decline while 6.3% Revenue growth
18 May 2016 Beximco Pharmaceuticals Net Income surged on 27.9% in 2015 and Revenue surged on 15.7%
Forgot password?
Sign Up
Sign In
